Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

TN14003

TN14003 is a CXCR4 inhibitor. TN14003 has antitumor activity[1].

Product Specifications

CAS Number

368874-31-1

UNSPSC

12352209

Target

CXCR

Type

Peptides

Related Pathways

GPCR/G Protein; Immunology/Inflammation

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/tn14003.html

Solubility

10 mM in DMSO

Smiles

O=C1[C@@]2([H])N(CCC2)C([C@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CSSC[C@H](NC([C@@H](NC([C@@H](NC([C@@H](N1)CC3=CC=C(C=C3)O)=O)CCCNC(N)=N)=O)CCCNC(N)=O)=O)C(N[C@H](C(N)=O)CCCNC(N)=N)=O)NC([C@@H](NC([C@H](CCCNC(N)=N)NC([C@@H](N)CCCNC(N)=N)=O)=O)CC4=CC5=C(C=CC=C5)C=C4)=O)=O)CC6=CC=C(C=C6)O)=O)CCCNC(N)=O)=O)CCCCN)=O)CCCCN)=O

Molecular Formula

C90H141N33O18S2

Molecular Weight

2037.42

References & Citations

[1]Lefort S, et al. CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients. Oncogene. 2017 Mar 2;36 (9) :1211-1222.

Shipping Conditions

Room temperature

Scientific Category

Peptides

Clinical Information

No Development Reported

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

DHRS4L2 HDR Plasmid (h)
sc-415470-HDR 20 µg

DHRS4L2 HDR Plasmid (h)

Sign In for Pricing
View Details
Olr1223 3'UTR Luciferase Stable Cell Line
TU214547 1.0 mL

Olr1223 3'UTR Luciferase Stable Cell Line

Sign In for Pricing
View Details
Ppef2 AAV siRNA Pooled Vector
37311164 1.0 µg

Ppef2 AAV siRNA Pooled Vector

Sign In for Pricing
View Details
JUND (Transcription Factor jun-D, Jun D Proto-oncogene)
483859 100 µL

JUND (Transcription Factor jun-D, Jun D Proto-oncogene)

Sign In for Pricing
View Details
EGFR (d746-750 T790M) Protein
MBS516877-01 0.01 mg

EGFR (d746-750 T790M) Protein

Sign In for Pricing
View Details
EGFR (d746-750 T790M) Protein
MBS516877-02 0.05 mg

EGFR (d746-750 T790M) Protein

Sign In for Pricing
View Details